I realize it sounds pollyannish to say this is a great time to be an investor. That was my first reaction when a longtime friend and colleague — who’s turned me on to more than a handful of 100%+ winners over the years — told me it was. Everywhere you look there’s reason to fear.…
DetailsOne of the best stocks to own over the last few years wasn’t very exciting… It didn’t have a cure for cancer or anything that was revolutionary. Nothing head turning… It’s not as if we uncovered the next Apple or Amazon. But what I did uncover was extreme value, a stock selling for 77% less…
DetailsSelf-driving cars are going to be the future. It’s inevitable, really. They offer everything. Safer. More efficient. Etc. The thing is though, they’re going to be the “car of the future” for a long, long time. It’s not going to be 2020 (which is only four years away now). Or 2030. Maybe 2040 they’ll be…
DetailsIt’s been one of the hottest biotechs we’ve bought over the last five years… Since recommending ACADIA Pharmaceuticals (ACAD) at $1.05 and $1.24 in 2010, we’ve watched the stock soar to $51.99 for gains of 4,851% and 4,093%. Every $1,000 risked is now worth well over $45,000. Every $5,000 risked is now well over $230,000.…
DetailsThe Dow Jones (DJIA) closed above 18,000 for the first time since July 2015. All would seem well for the average investor… or so we think. Unfortunately, the stock market and the economy seem to be moving in opposite directions. For example, even as stock prices rally near historic highs, corporations are defaulting on debt…
DetailsI’ve decided to call this “The BEST Investment Story I’ve Ever Heard.” Certainly a bit of hyperbole there, I realize. It’s a great story though. Could be the best. I just really wanted you to read this story because knowing what created it and what happened in the end will help you become a better…
DetailsSometimes the most beautiful returns come from the most ignored stocks on the market. We’ve proven that dozens of times over the last 30+ years, in fact. For example, in the October 2015 edition of The Cheap Investor, we noted NNVC was being ignored 46% off June 2015 highs. After finding that it had several…
DetailsDo you like solar stocks? Do you think alternative energy is the way of the future? Did you consider just closing out this message once I mentioned alternative energy? Or are you just looking for early-stage growth potential within an otherwise stagnant economy? If you said yes to any of those, I think this is…
DetailsThe Dow Jones Industrial Average (DJIA) topped 18,000 for the first time since July 2015. It’s now within striking distance of its all-time high of 18,351. That’s a stark change from where 2016 began, thanks in part to the oil rally from a low of $26.05 to more than $42.88 a barrel. Much of that…
DetailsAre you worried about a stock market drop? I’m afraid the worries are completely justified. The Dow passed 18,000 yesterday for third time ever. Each time though it has failed to pass 19,000 and there are no clear catalysts to drive it past those highs. Technical analysts call that “resistance” and it’s often a major…
DetailsIn late 2014, shares of Pain Therapeutics plunged from a high of $4.25 to less than $1.75 after Pfizer ended an agreement to help it develop and market the Remoxy pain drug along with Durect Corporation. Since then, PTIE has been greatly ignored. However, in July 2015, we found value, recommending the stock at just…
DetailsIn January 2016, the Dow Jones Industrial Average lost up to 2,200 points. Since then, the index has had a tremendous 16% rally from 15,503 to more than 17,926. Stocks have rebounded well out of bear market territory. Oil has rallied from a low of $26.05 to a high of $42.65 on hopes OPEC and…
Details